Skip to content

ARQUENNES PHARMA

Active Public limited companyfounded 1991active for 35 yearsChaussée de Nivelles 141, 7181 SeneffeKBO/BCE: BE 0442.964.356

Lifetime

20 annual accounts with figures on one time axis, 35 filings since 1991
peak of €483,106 in 2024
€462,062▼ 4.4%
lowest -€13,166 in 2006
€132,377▲ 8.7%
peak of €238,406 in 2025
€238,406▲ 1.0%
€474,162▼ 17.3%
peak of 4.3 FTE in 2024
4 FTE▼ 7.0%
Board4 names since 2008
4 directors and 3 others
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
2 directors resigning 18-08Debts from €573,620 to €474,162Investments €23,758

Key points

from the 2025 annual accounts

Equity

€238,406 ▲ 1.0%

ARQUENNES PHARMA has made a profit without a break since 2009.

Investments

€23,758 1.9 times depreciation
20232025

Green is investment, beige is depreciation.

Filings

35 annual accounts since 1991
AprilJune31 JulyOctober200020102020

Six of the last ten came late. The 2019 accounts came in latest, 89 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,388 companies had the same profile as ARQUENNES PHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,388 companies, not a prediction for ARQUENNES PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair
Managing director,
Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0442964356
2 directors resigning and (day-to-day manager) · acts as permanent representative · General meeting of 06-05-2025 · Gazette deed
3 directors appointed, 4 reappointments , , and reappointed · and act as permanent representatives · , and appointed · General meeting of 26-12-2023 · Gazette deed
2 directors appointed, 2 resignations (managing director) and resign · (managing director) and appointed · and act as permanent representatives · General meeting of 12-12-2016 · Gazette deed
All 51 events

Comparable companies

same main activity, similar in size and age
Company
ARQUENNES PHARMA Seneffe €712,567 €462,062 33.5% 4
PHARMACIE DE LA SALM Vielsalm €778,399 €449,619 58.2% 4.2
CEGEPHAR Fléron €787,032 €487,011 25.5% 4.4
PHARMACIE MAILLEUX Eghezée €620,340 €451,067 81.9% 4
APOTHEKE MERTENS Eupen €668,099 €441,255 14.8% 4
Apotheek Baute Antwerp €688,288 €378,303 48.6% 3.8
PHARMACIE R. WALNIER Faimes €716,577 €463,240 72.6% 4.7

These companies have the same main activity as ARQUENNES PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €620,000 and €787,000, founded between 1986 and 1997.

Official details

Source: KBO
Status
Active since 07-01-1991Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.051.353.1297181 Seneffe, since 04-02-1991
Financial year end
31 December
Peppol
Reachable since 29-06-2026
Company details

Annual accounts 2025

≈ €1.6mestimated
€712,567▼ 12.0%
Employeeson 31-12-2025
5▼ 16.7%
Filing
Filed on 31-08-2026
Financials

Insights on ARQUENNES PHARMA

ARQUENNES PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €67,718 in 2006 to €462,062 in 2025.

The balance sheet grew most from 2012 to 2014 through fixed assets.

In January 2024, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ARQUENNES PHARMA

What is the company number of ARQUENNES PHARMA?
The company number of ARQUENNES PHARMA is 0442.964.356. The VAT number is the same number with BE in front: BE 0442.964.356.
Where is ARQUENNES PHARMA based?
The registered office is at Chaussée de Nivelles 141, 7181 Seneffe.Company details
What does ARQUENNES PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of ARQUENNES PHARMA?
ARQUENNES PHARMA is a public limited company (NV).
When was ARQUENNES PHARMA founded?
ARQUENNES PHARMA was founded on 07-01-1991.
Is ARQUENNES PHARMA still active?
Yes, ARQUENNES PHARMA is an active enterprise in the KBO register.
How many employees does ARQUENNES PHARMA have?
ARQUENNES PHARMA had an average of 4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does ARQUENNES PHARMA fall under?
In its 2025 annual accounts, ARQUENNES PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of ARQUENNES PHARMA?
The turnover in financial year 2025 is about €1.6m. This figure is estimated from the gross margin of €462,062 and 42 comparable companies (NACE 477). It probably lies between €1.3m and €2.2m.
Is ARQUENNES PHARMA profitable?
In financial year 2025, ARQUENNES PHARMA made a profit of €132,377.
Where can I find the annual accounts of ARQUENNES PHARMA?
ARQUENNES PHARMA filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ARQUENNES PHARMA due?
ARQUENNES PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.